• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Celmatix Sues Research Partner 23andMe for $100M

    FDA Cleared New Cochlear Osia 2 System

    FDA Approves First Nasal Rescue Treatment for Frequent Seizure Activity

    Lens-Free Microendoscope Generates High Quality Images

    Roche's Blood Glucose Reading Smartphone App Gains CE Mark
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    From Genome Sequencing to the World’s First Portable MRI

    An Update on Digital Health

    ‘If You’re Reading This, You Need to Be at This Meeting’

    Five Steps for Succeeding Globally in Medtech

    Unlocking Market Doors with Real-World Evidence
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    K-Tube Technologies

    S-Y-M Products Company

    Zeus

    Carclo Technical Plastics

    Pulse Systems
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Localizing Medical Devices

    Sounding Board: Looking Back at 2019 and Gazing at 2020

    Understanding Key Processes for Mixing APIs with Silicone

    How to Minimize Color Variations in Your Medical Device

    Don’t Touch: Gesture Tech Is Reshaping How We Interact with Devices
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    GS Plastic Optics

    Fusion Biotec Inc.

    Zeus

    RJG Inc.

    Command Medical Products Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    ALung Initiates Enrollment in Pivotal Trial of the Hemolung RAS for U.S. Market

    Study is being conducted under an Investigational Device Exemption received late last year from the FDA.

     ALung Initiates Enrollment in Pivotal Trial of the Hemolung RAS for U.S. Market
    Related CONTENT
    • FDA Approves First Test to Screen Zika Virus in Blood Donations
    • ALung Receives IDE Approval to Conduct VENT-AVOID Trial of the Hemolung RAS for the U.S. Market
    • FDA Clears Philips' 'Small Parts' Ultrasound Imaging
    • FDA Warns Magellan Diagnostics of Possible Federal Law Violations
    • FDA Commissioner Declares New Steps to Advance Medical Device Innovation
    Business Wire03.27.18
    ALung Technologies Inc. has initiated patient enrollment in its VENT-AVOID Trial of the Hemolung RAS. The Minneapolis Heart Institute Foundation recently enrolled the first study subject at Abbott Northwestern Hospital in Minneapolis, Minn. The VENT-AVOID Trial is the world’s first pivotal trial of extracorporeal carbon dioxide removal (ECCO2R) for treating patients with COPD exacerbations. The study is being conducted under an Investigational Device Exemption (IDE) which ALung received from the U.S. Food and Drug Administration (FDA) in late 2017.
     
    “We are excited to be working with institutions like Minneapolis Heart Institute Foundation to enroll patients in the VENT-AVOID Trial,” said Peter DeComo, chairman and CEO of ALung. “We are very grateful for their efforts to enroll their first patient and look forward to their continued participation in the study.”
     
    The VENT-AVOID Trial is a prospective, multi-center, randomized, controlled, pivotal trial to validate the safety and efficacy of the Hemolung Respiratory Assist System for COPD patients experiencing an acute exacerbation requiring ventilatory support. COPD patients suffering severe exacerbations are potentially eligible for the study if they are either 1) failing non-invasive ventilation and presenting a high risk of being intubated and mechanically ventilated or 2) have required intubation and invasive mechanical ventilation due to acute respiratory failure.
     
    Leading the study at Minneapolis Heart Institute Foundation is Dr. Ramiro Saavedra-Romero, an intensivist and director of Medical ECMO Program, and medical director of MICU/SICU at Abbott Northwestern Hospital. “We’re very proud to be the first study site to enroll in the VENT-AVOID Trial,” noted Dr. Saavedra-Romero. “I see the promise in extracorporeal carbon dioxide removal as a new and safe treatment modality when traditional methods of ventilatory support are failing or deemed undesirable.”
     
    COPD affects 30 million Americans1 and is the third leading cause of death in the United States behind cancer and heart disease.2 Acute exacerbations, defined as a sudden worsening of COPD symptoms, are a major cause of morbidity and mortality in COPD patients. For patients with severe exacerbations, high levels of carbon dioxide can result in respiratory failure and the need for intubation and mechanical ventilation as life saving measures. Unfortunately, mechanical ventilation is associated with many side effects, and in-hospital mortality remains as high as 30 percent.3 ECCO2R therapy with the Hemolung RAS allows carbon dioxide to be removed from the blood independently of the lungs with the aim of facilitating the avoidance or reduction of intubation and invasive mechanical ventilation.
     
    In addition to the US-based VENT-AVOID study, The Hemolung RAS is also being studied in a landmark pivotal study for patients with acute respiratory distress syndrome (ARDS) as part of the 1,120-patient REST Trial in the United Kingdom. Nearly 200 patients have been enrolled in the REST Trial, making it the largest trial of ECCO2R to date. ALung is the only company pursuing two major pivotal trials to validate the safety and efficacy of extracorporeal carbon dioxide removal therapy.
     
    ALung Technologies Inc. is a privately-held Pittsburgh, Pa.-based developer and manufacturer of innovative lung assist devices. Founded in 1997 as a spin-out of the University of Pittsburgh, ALung has developed the Hemolung RAS as a dialysis-like alternative or supplement to mechanical ventilation. ALung is backed by Philips, UPMC Enterprises, Abiomed, The Accelerator Fund, Allos Ventures, Birchmere Ventures, Blue Tree Ventures, Eagle Ventures, Riverfront Ventures, West Capital Advisors, and other individual investors.
     
    The Hemolung RAS is an investigational device and limited by United States law to investigational use.
     
    The Minneapolis Heart Institute Foundation (MHIF) is a recognized research leader in cardiovascular medicine and population health initiatives. Each year MHIF leads more than 175 active research projects and publishes more than 175 peer-reviewed abstracts. MHIF provides more than 10,000 hours of education each year putting its research into practice to improve outcomes.

    References
    1. https://www.copdfoundation.org/What-is-COPD/COPD-Facts/Statistics.aspx
    2. http://www.lung.org/assets/documents/research/copd-trend-report.pdf
    3. Chandra D, Stamm JA, Taylor B, et al. Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998-2008. Am J Respir Crit Care Med. Jan 15 2012;185(2):152-159.
    Related Searches
    • ct
    • market
    • intubation
    • university of pittsburgh
    Suggested For You
    Monteris Medical NeuroBlate System Recalled Over Unexpected Laser Delivery Probe Heating Monteris Medical NeuroBlate System Recalled Over Unexpected Laser Delivery Probe Heating
    FDA Expands Heart Valve Approval to Include Size for Newborn Patients FDA Expands Heart Valve Approval to Include Size for Newborn Patients
    Philips and Hologic Partner to Provide Integrated Women Philips and Hologic Partner to Provide Integrated Women's Health Imaging Solutions
    Philips Launches Digital Ingenia Elition 3.0T MRI Philips Launches Digital Ingenia Elition 3.0T MRI
    Philips Recalls HeartStart MRx Defibrillator Due to Defects in Gas Discharge Tubes Philips Recalls HeartStart MRx Defibrillator Due to Defects in Gas Discharge Tubes
    Medtronic and Philips Partner to Advance Lung Cancer Management Medtronic and Philips Partner to Advance Lung Cancer Management
    FDA Warns BD About Blood Collection Tubes Used in Lead Testing Kit FDA Warns BD About Blood Collection Tubes Used in Lead Testing Kit
    CES 2018: Philips and American Well Form Global Partnership in Telehealth CES 2018: Philips and American Well Form Global Partnership in Telehealth
    FDA Approves First Breakthrough-Designated Next-Gen Sequencing IVD Cancer Test FDA Approves First Breakthrough-Designated Next-Gen Sequencing IVD Cancer Test
    RSNA News: Philips Launches New MR Solutions to Support Diagnostic Confidence RSNA News: Philips Launches New MR Solutions to Support Diagnostic Confidence
    Employee Feedback Should Be Part of a Product Safety Plan Employee Feedback Should Be Part of a Product Safety Plan
    Medtech Mettle: The 2017 Year in Review Medtech Mettle: The 2017 Year in Review
    FDA Reaches Agreement with Philips North America Over Quality Control Issues FDA Reaches Agreement with Philips North America Over Quality Control Issues
    FDA Commissioner Declares New Steps to Advance Medical Device Innovation FDA Commissioner Declares New Steps to Advance Medical Device Innovation
    FDA Warns Magellan Diagnostics of Possible Federal Law Violations FDA Warns Magellan Diagnostics of Possible Federal Law Violations

    Related Breaking News

    • Celmatix Sues Research Partner 23andMe for $100M

      Celmatix Sues Research Partner 23andMe for $100M

      Celmatix claims breaches of the parties' agreement and tortious interference with efforts to raise capital.
      PR Newswire 12.11.19

    • FDA Cleared New Cochlear Osia 2 System

      FDA Cleared New Cochlear Osia 2 System

      The world’s first active osseointegrated steady-state implant.
      Cochlear 12.11.19

    • Neurological
      FDA Approves First Nasal Rescue Treatment for Frequent Seizure Activity

      FDA Approves First Nasal Rescue Treatment for Frequent Seizure Activity

      Aptar’s Unidose Liquid System can deliver a formulation in an emergency situation quickly and easily and be administered by a non-healthcare professional.
      Business Wire 12.10.19


    • Diagnostics
      Lens-Free Microendoscope Generates High Quality Images

      Lens-Free Microendoscope Generates High Quality Images

      It also doesn't require movement to focus on objects at different depths.
      Johns Hopkins University 12.10.19

    • Patient Monitoring | Software & IT
      Roche

      Roche's Blood Glucose Reading Smartphone App Gains CE Mark

      The app determines blood glucose ranges by taking photos with the smartphone camera without the need for a blood glucose meter.
      GlobeNewswire 12.10.19

    • FDA BDP Designation for the iLet Bionic Pancreas System

      FDA BDP Designation for the iLet Bionic Pancreas System

      The world’s first fully automated bionic pancreas.
      Beta Bionics 12.10.19


    • Diagnostics
      NeuMoDx Molecular and Sentinel Diagnostics Partner

      NeuMoDx Molecular and Sentinel Diagnostics Partner

      Work together to develop multiple new assays for the NeuMoDx Molecular Systems.
      NeuMoDx Molecular 12.10.19

    • Neural Analytics Enrolls First Patient With Its Next-Generation Lucid Robotic System

      Neural Analytics Enrolls First Patient With Its Next-Generation Lucid Robotic System

      The new IDE version of the technology is intended to improve performance and ease of use for the company’s robotic platform.
      Business Wire 12.10.19

    • Cardiovascular | Neurological
      Imperative Care Closes a Series C Financing of $85 Million for Stroke Treatments

      Imperative Care Closes a Series C Financing of $85 Million for Stroke Treatments

      The funds will support the commercial launch of the company’s portfolio.
      Imperative Care Inc. 12.10.19


    • Contract Manufacturing
      Medical Murray Holds Open House

      Medical Murray Holds Open House

      Event centered around new 35,000 square foot facility.
      Medical Murray 12.10.19

    • Cardiovascular
      FDA Grants Supplemental-PMA Approval to Impulse Dynamics

      FDA Grants Supplemental-PMA Approval to Impulse Dynamics' Next-Generation Optimizer Smart System

      Product offers a new therapy for heart failure patients with reduced ejection fraction.
      Businesswire 12.10.19

    • OmniGuide Holdings Expands Executive Team

      OmniGuide Holdings Expands Executive Team

      Company hires global marketing VP and managing director of Surgical Strategic Business Unit.
      Businesswire 12.10.19

    • Survey: Device Tax

      Survey: Device Tax's Return Will Harm Innovation

      Medical Alley Association survey shows 83 percent of respondents will be decreasing R&D spending if tax is reinstated.
      Business Wire 12.10.19

    • Surgical
      CMR Surgical Taps New CEO

      CMR Surgical Taps New CEO

      Per Vegard Nerseth joins the company from ABB.
      CMR Surgical 12.09.19

    • Diagnostics
      Companies Partner to Develop Instrument-Free Molecular Diagnostic Tests

      Companies Partner to Develop Instrument-Free Molecular Diagnostic Tests

      Collaboration facilitated by the Bill & Melinda Gates Foundation through an expansion of an existing grant.
      Business Wire 12.09.19


    Breaking News
    • Celmatix Sues Research Partner 23andMe for $100M
    • FDA Cleared New Cochlear Osia 2 System
    • FDA Approves First Nasal Rescue Treatment for Frequent Seizure Activity
    • Lens-Free Microendoscope Generates High Quality Images
    • Roche's Blood Glucose Reading Smartphone App Gains CE Mark
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • Adding Fabrication Capabilities: Additive Manufacturing for Production Parts
    • Delivering the Goods: The Evolving World of Combination Products
    • Anxious Undertones: The 2019 Year in Review
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Beckers Group Announces Global Price Increase on Coil, Industrial Coatings
    Evonik, Wynca Celebrate Groundbreaking of New Fumed Silica Plant in Zhenjiang
    Personnel Changes in Corporate Communications, Government Relations at BASF
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Celmatix Sues Research Partner 23andMe for $100M
    FDA Cleared New Cochlear Osia 2 System
    FDA Approves First Nasal Rescue Treatment for Frequent Seizure Activity
    Contract Pharma

    Latest Breaking News From Contract Pharma

    CatSci Expands Capabilities with Lab Expansion
    Smart Tags on Pills Set to Improve Supply Chain Security and Patient Adherence
    PCI Pharma Services Invests in Tredegar, UK Site
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Star of E!'s Botched Gets Line Leaping Bunny Certified
    Happi

    Latest Breaking News From Happi

    Birchbox Partners with Buzzfeed
    Coty Strengthens Its Leadership
    Jennifer Garner Joins Virtue Labs
    Ink World

    Latest Breaking News From Ink World

    Smurfit Kappa, Wings for Aid Create Disaster Relief Packaging Solution
    ePac Flexible Packaging Expands into Asia Pacific Market
    United Carton Industries Company Invests in EFI Nozomi Corrugated Printer
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Materials Exchange launches to solve excess inventory issue
    Mark Andy joins forces with UPM Raflatac
    Omet India opens in New Delhi
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Simavita Set to License Sensor Technology in EU
    NDC Appoints President
    AATC Adds Two Scholarships
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System
    OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application
    Tyber Medical Opens $8M Office and Manufacturing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    SEMI Releases Global Semiconductor Equipment Sales Forecast
    eMagin Corporation Announces Approximately $4.3 Million Order for Military Program
    CPI Supports Smart Food-labeling Project Set to Reduce Food Waste in 2020

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.